Racura Oncology LtdASX: RAC

Sheba Grants Ethics Approval for EMILI AML Trial

· Issued by Racura Oncology Ltd via ASX

Filed with ASX · · 9 pages · English

Release

ASX Announcement Sheba Medical Center Grants Approval for the EMILI 2b/3 AML Trial § Sheba Medical Center in Israel has granted site ethics approval for the pivotal EMILI Phase 2b/3 trial of RC220 in relapsed or refractory acute myeloid leukaemia (R/R AML) § Racura Board has approved the...

Racura Oncology Ltd on 6ix

In the deck

Earlier from Racura Oncology

Later from Racura Oncology

All Racura Oncology news releases